Drug Profile
TD 5471
Alternative Names: TD-5471Latest Information Update: 16 May 2016
Price :
$50
*
At a glance
- Originator Theravance Biopharma
- Class
- Mechanism of Action Beta 2 adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Asthma; Chronic obstructive pulmonary disease
Most Recent Events
- 16 May 2016 Chemical information added